Anika Therapeutics ANIK
NASDAQ ANIK
$19.76 -0.18 (-0.93%)
As of: Sep 30, 2026 · 12:57 PM EDT

Anika Therapeutics, Inc. (ANIK) EV to EBITDA (2011 - 2026)

Updated

Anika Therapeutics' EV to EBITDA came in at 307.39 for Q2 2026.

Analysis

Anika Therapeutics, Inc. (ANIK) EV to EBITDA (2011 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Anika Therapeutics reported EV to EBITDA of -138.19; for FY2024, it was 52.34, up 232.5% from FY2023.

  • Going back by year, EV to EBITDA was 15.74 in FY2023 (-8.4%), 17.18 in FY2022 (-26.0%) and 23.22 in FY2021.
  • The Q2 2026 figure represents the highest quarterly EV to EBITDA in data going back to Q2 2011.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 307.39
Mar 31, 2025 181.96
Dec 31, 2024 52.34
Sep 30, 2024 9.02
Jun 30, 2024 11.66
Mar 31, 2024 11.67
Dec 31, 2023 15.74
Sep 30, 2023 24.42
Jun 30, 2023 32.13
Mar 31, 2023 34.43
Dec 31, 2022 17.18
Mar 31, 2022 20.03
Dec 31, 2021 23.22
Sep 30, 2021 66.48
Jun 30, 2020 17.11
Mar 31, 2020 7.56
Dec 31, 2019 14.21
Sep 30, 2019 13.51
Jun 30, 2019 10.04
Mar 31, 2019 6.42
API Access

Anika Therapeutics, Inc. EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ANIK&period=max&api_key=YOUR_API_KEY